Benralizumab
Catalogue number:
HY-P9923-2mg
Supplier:
Size:
2 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
Apoptosis;Interleukin Related
Alternative Names:
MEDI-563; BIW-8405; KHK4563
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma[1].